| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.42B | 4.36B | 4.28B | 3.89B | 3.35B |
| Gross Profit | 1.75B | 1.72B | 1.60B | 1.53B | 1.28B |
| EBITDA | 349.40M | 389.35M | 365.61M | 294.81M | 249.25M |
| Net Income | 199.93M | 256.88M | 236.59M | 178.88M | 196.43M |
Balance Sheet | |||||
| Total Assets | 2.53B | 2.34B | 1.90B | 1.63B | 1.34B |
| Cash, Cash Equivalents and Short-Term Investments | 1.41B | 1.34B | 895.11M | 737.08M | 566.43M |
| Total Debt | 0.00 | 0.00 | 0.00 | 34.04M | 104.33M |
| Total Liabilities | 934.47M | 890.65M | 874.99M | 854.46M | 742.37M |
| Stockholders Equity | 1.59B | 1.45B | 1.02B | 777.04M | 594.70M |
Cash Flow | |||||
| Free Cash Flow | 285.03M | 315.20M | 204.44M | 220.83M | 295.50M |
| Operating Cash Flow | 285.62M | 367.41M | 271.75M | 266.89M | 330.84M |
| Investing Cash Flow | -142.62M | -81.36M | -79.67M | -25.94M | -40.14M |
| Financing Cash Flow | -97.17M | 163.12M | -34.04M | -70.29M | -277.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥3.57B | 7.45 | ― | 1.93% | -1.00% | 105.56% | |
74 Outperform | ¥2.73B | 13.49 | ― | 3.31% | -1.83% | -10.37% | |
70 Outperform | ¥3.37B | 13.65 | ― | 3.30% | -3.41% | -24.95% | |
66 Neutral | ¥3.64B | 10.58 | ― | 3.69% | 0.62% | -24.08% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥115.72B | 35.71 | 19.59% | 0.16% | 18.08% | 136.77% | |
61 Neutral | ¥5.77B | 19.83 | ― | 2.72% | -1.30% | ― |